Matrox unveils low profile controller boards at JSMRM

TriMed Staff | | Health Imaging | Screening
Matrox Graphics Inc. introduced two new display controller boards for low profile workstations, Low Profile RAD2mp and Low Profile RAD3mp, at the annual meeting of the Japanese Society of Magnetic Resonance in Medicine (JSMRM) in Otsu, Japan, Sept. 16 - 18.

Matrox said the new boards offer dual output support of up to 2-megapixel (MP) and 3 MP grayscale or color, analog or digital displays respectively, and come equipped with hardware pivot for smooth and accelerated portrait image displays. The low profile boards are also capable of driving various combinations of color and grayscale displays in stretched or independent modes, and feature Matrox's real-time grayscale processing technology, ExtendiGray.

TriMed Staff

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.